Sign inGet started

Canaan Partners IX LLC

Insider CIK 1654586 · CTMX Director, 10% owner · REAL 10% owner · ARVN 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ARVN ARVINAS, INC. J Other2020-10-142020-10-15400,000— $03,589,554SEC↗
ARVN ARVINAS, INC. J Other2020-07-202020-07-21500,000— $03,989,554SEC↗
REAL TheRealReal, Inc. J Other2020-01-142020-01-16881,000— $07,925,919SEC↗
REAL TheRealReal, Inc. C Conversion deriv2019-07-022019-07-02427,020— $00SEC↗
REAL TheRealReal, Inc. C Conversion deriv2019-07-022019-07-02654,298— $00SEC↗
REAL TheRealReal, Inc. C Conversion deriv2019-07-022019-07-021,790,580— $00SEC↗
REAL TheRealReal, Inc. C Conversion deriv2019-07-022019-07-022,214,825— $00SEC↗
REAL TheRealReal, Inc. C Conversion deriv2019-07-022019-07-024,120,823— $00SEC↗
REAL TheRealReal, Inc. C Conversion deriv2019-07-022019-07-027,398,272— $00SEC↗
REAL TheRealReal, Inc. C Conversion2019-07-022019-07-023,699,136— $04,203,147SEC↗
REAL TheRealReal, Inc. C Conversion2019-07-022019-07-02213,510— $08,806,919SEC↗
REAL TheRealReal, Inc. C Conversion2019-07-022019-07-02327,149— $08,593,409SEC↗
REAL TheRealReal, Inc. C Conversion2019-07-022019-07-02895,290— $08,266,260SEC↗
REAL TheRealReal, Inc. C Conversion2019-07-022019-07-021,107,412— $05,310,559SEC↗
REAL TheRealReal, Inc. C Conversion2019-07-022019-07-022,060,411— $07,370,970SEC↗
ARVN ARVINAS, INC. J Other2019-06-102019-06-12500,000— $04,489,554SEC↗
ARVN ARVINAS INC. C Conversion deriv2018-10-012018-10-034,462,837— $00SEC↗
ARVN ARVINAS INC. C Conversion deriv2018-10-012018-10-032,209,833— $00SEC↗
ARVN ARVINAS INC. C Conversion deriv2018-10-012018-10-039,543,387— $00SEC↗
ARVN ARVINAS INC. C Conversion2018-10-012018-10-034,989,554— $04,989,554SEC↗
CTMX CytomX Therapeutics, Inc. J Other2017-03-272017-03-28750,000— $02,494,381SEC↗
CTMX CytomX Therapeutics, Inc. J Other2016-11-302016-12-01400,000— $03,244,381SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-11-292016-12-0122,086$11.18 $246.9K3,644,381SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-11-282016-11-2820,840$11.33 $236.1K3,666,467SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-11-252016-11-286,729$11.79 $79.3K3,687,307SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-11-232016-11-2810,890$11.84 $128.9K3,694,036SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-11-222016-11-2242,550$11.71 $498.3K3,704,926SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-11-212016-11-2113,548$11.72 $158.8K3,747,476SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-11-182016-11-2112,805$11.64 $149.1K3,761,024SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-11-172016-11-2118,971$11.50 $218.2K3,773,829SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-11-162016-11-1618,517$11.55 $213.9K3,792,800SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-11-152016-11-1633,064$11.48 $379.6K3,811,317SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-11-142016-11-1423,744$11.21 $266.2K3,844,381SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-11-112016-11-1435,391$11.20 $396.4K3,868,125SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-11-102016-11-1427,135$11.07 $300.4K3,903,516SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-11-092016-11-1013,730$11.03 $151.4K3,930,651SEC↗
CTMX CytomX Therapeutics, Inc. J Other2016-10-112016-10-12300,000— $03,944,381SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-06-102016-06-102,700$10.01 $27.0K4,244,381SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-06-092016-06-1022,842$10.06 $229.8K4,247,081SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-06-082016-06-1022,885$10.08 $230.7K4,269,923SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-06-072016-06-089,731$10.03 $97.6K4,292,808SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-06-062016-06-08101,767$10.01 $1.02M4,302,539SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-06-032016-06-0618,428$10.83 $199.6K4,404,306SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-06-022016-06-0641,193$10.79 $444.5K4,422,734SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-06-012016-06-0222,463$10.75 $241.5K4,463,927SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-05-272016-06-0125,082$10.60 $265.9K4,486,390SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-05-262016-05-2739,887$10.43 $416.0K4,511,472SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-05-252016-05-2711,456$10.02 $114.8K4,551,359SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-05-242016-05-251,200$10.00 $12.0K4,562,815SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-05-232016-05-2512,053$10.10 $121.7K4,564,015SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-05-202016-05-236,187$10.09 $62.4K4,576,068SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2016-05-192016-05-232,500$10.14 $25.4K4,582,255SEC↗
CTMX CytomX Therapeutics, Inc. J Other2016-04-252016-04-26300,000— $04,584,755SEC↗
CTMX CytomX Therapeutics, Inc. C Conversion deriv2015-10-142015-10-161,318,418— $00SEC↗
CTMX CytomX Therapeutics, Inc. C Conversion deriv2015-10-142015-10-163,566,337— $00SEC↗
CTMX CytomX Therapeutics, Inc. C Conversion2015-10-142015-10-164,884,755— $04,884,755SEC↗